Pathogenic KRAS variants disrupt structure and dynamics: Insights from integrated computational analyses
PLOS One · 2026
DOI: 10.1371/journal.pone.0341219 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Saqib Ishaq und 8 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of System Biology and Synthetics Biology for Urogenital Tumors, School of Basic Medicine, Shenzhen University Med…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins p21(ras), Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
KRAS is among the most frequently mutated oncogenes in pancreatic, colorectal, and lung cancers, yet the structural and dynamic mechanisms by which specific coding variants alter its function remain poorly understood. This study employs an extensive in-silico protocol to identify the most detrimental non-synonymous single nucleotide polymorphisms (nsSNPs) within the KRAS gene.
Objective
To identify and describe pathogenic non-synonymous single nucleotide polymorphisms (nsSNPs) in KRAS and elucidate their atomistic effects on structure, stability, and potential oncogenic initiation.
Methods
A total of 173 nsSNPs were screened operating an integrated computational workflow combining pathogenicity prediction, evolutionary conservation assay, high-resolution structural modeling, molecular docking, atomistic molecular dynamics simulations, post-translational modification mapping, and protein–protein interaction assessment.
Results
Four high-impact variants (L79P, A130P, G138E, and F141L) were determined as the most deleterious. Simulations revealed distinct perturbations in conformational stability (RMSD), residue flexibility (RMSF), hydrogen bonding patterns, and binding energetics compared with the wild type, signifying mutation-induced destabilization and potential impairment of KRAS regulatory function. Notably, these variants are primarily associated with colorectal, pancreatic, and lung cancers, underscoring their clinical significance.
Conclusion
This integrative examination provides mechanistic insightinto how specific KRAS variations may prompt oncogenic activation. The identified alterations represent high-priority targets for experimental confirmation, illuminating the power of computational techniquesin linking sequence variationand functional consequence in cancer biology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of System Biology and Synthetics Biology for Urogenital Tumors, School of Basic Medicine, Shenzhen University Medical School, Shenzhen University (SZU), Shenzhen, Guangdong, China.
- Department of Computer Sciences and Bioinformatics, Khushal Khan Khattak University Karak, Karak, Pakistan.
- Center of Biotechnology and Microbiology, University of Peshawar, Peshawar, Pakistan.
- Department of Biotechnology, Abdul Wali Khan University Mardan, Mardan, KPK, Pakistan.
- School of Medicine, the Chinese University of Hong Kong, Shenzhen, China.
- Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
ORCID-Profile: Saqib Ishaq
Zitieren
APA
Ishaq, S., Ali, A., Habib, O., Usmani, S. A., Rehman, I. U., Aziz, A., Ali, Y., Ahmad, A., & Ullah, A. (2026). Pathogenic KRAS variants disrupt structure and dynamics: Insights from integrated computational analyses. PLOS One. https://doi.org/10.1371/journal.pone.0341219
Vancouver
Ishaq S, Ali A, Habib O, Usmani SA, Rehman IU, Aziz A, et al. Pathogenic KRAS variants disrupt structure and dynamics: Insights from integrated computational analyses. PLOS One. 2026. doi:10.1371/journal.pone.0341219
BibTeX
@article{Ishaq2026,
author = {Ishaq, Saqib and Ali, Aizaz and Habib, Obaid and Usmani, Shabir Ahmad and Rehman, Irshad Ur and Aziz, Abdul and Ali, Yasir and Ahmad, Ajaz and Ullah, Amin},
title = {Pathogenic KRAS variants disrupt structure and dynamics: Insights from integrated computational analyses},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0341219}
}
EUVIMED